Annual Shareholders Equity
$21.21 M
-$420.21 K-1.94%
31 December 2023
Summary:
Sunshine Biopharma annual stockholders equity is currently $21.21 million, with the most recent change of -$420.21 thousand (-1.94%) on 31 December 2023. During the last 3 years, it has risen by +$22.16 million (+2321.05%). SBFMW annual shareholders equity is now -1.94% below its all-time high of $21.63 million, reached on 31 December 2022.SBFMW Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$25.04 M
+$1.55 M+6.60%
30 September 2024
Summary:
Sunshine Biopharma quarterly stockholders equity is currently $25.04 million, with the most recent change of +$1.55 million (+6.60%) on 30 September 2024. Over the past year, it has increased by +$3.08 million (+14.00%). SBFMW quarterly shareholders equity is now -40.22% below its all-time high of $41.89 million, reached on 30 June 2022.SBFMW Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | +14.0% |
| 3 y3 years | +2321.1% | +2232.9% |
| 5 y5 years | +10000.0% | +3470.7% |
SBFMW Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.9% | +2321.1% | -40.2% | +2232.9% |
| 5 y | 5 years | -1.9% | +2321.1% | -40.2% | +2232.9% |
| alltime | all time | -1.9% | +2321.1% | -40.2% | +2232.9% |
Sunshine Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.04 M(+6.6%) |
| June 2024 | - | $23.49 M(-5.4%) |
| Mar 2024 | - | $24.82 M(+17.0%) |
| Dec 2023 | $21.21 M(-1.9%) | $21.21 M(-3.4%) |
| Sept 2023 | - | $21.96 M(-5.0%) |
| June 2023 | - | $23.11 M(+18.9%) |
| Mar 2023 | - | $19.43 M(-10.2%) |
| Dec 2022 | $21.63 M(>+9900.0%) | $21.63 M(-46.4%) |
| Sept 2022 | - | $40.38 M(-3.6%) |
| June 2022 | - | $41.89 M(+214.6%) |
| Mar 2022 | - | $13.31 M(+6190.3%) |
| Dec 2021 | $211.66 K(-122.2%) | $211.66 K(-118.0%) |
| Sept 2021 | - | -$1.17 M(+34.5%) |
| June 2021 | - | -$872.71 K(-19.5%) |
| Mar 2021 | - | -$1.08 M(+13.6%) |
| Dec 2020 | -$954.84 K(+29.8%) | -$954.84 K(+72.1%) |
| Sept 2020 | - | -$554.88 K(-9.2%) |
| June 2020 | - | -$610.91 K(-13.8%) |
| Mar 2020 | - | -$708.61 K(-3.6%) |
| Dec 2019 | -$735.38 K(+1219.0%) | -$735.38 K(-1.0%) |
| Sept 2019 | - | -$742.86 K(-9.0%) |
| June 2019 | - | -$816.30 K(+285.5%) |
| Mar 2019 | - | -$211.77 K(+279.8%) |
| Dec 2018 | -$55.75 K(-90.3%) | -$55.75 K(-224.8%) |
| Sept 2018 | - | $44.66 K(-116.2%) |
| June 2018 | - | -$276.13 K(-44.8%) |
| Mar 2018 | - | -$500.69 K(-12.7%) |
| Dec 2017 | -$573.36 K(+173.4%) | -$573.36 K(+62.0%) |
| Sept 2017 | - | -$353.87 K(-42.6%) |
| June 2017 | - | -$616.29 K(+136.1%) |
| Mar 2017 | - | -$261.04 K(+24.5%) |
| Dec 2016 | -$209.70 K(-64.9%) | -$209.70 K(-165.0%) |
| Sept 2016 | - | $322.64 K(-158.8%) |
| June 2016 | - | -$548.37 K(+54.3%) |
| Mar 2016 | - | -$355.39 K(-40.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -$597.04 K(+54.0%) | -$597.04 K(+79.3%) |
| Sept 2015 | - | -$332.93 K(+25.5%) |
| June 2015 | - | -$265.32 K(+15.1%) |
| Mar 2015 | - | -$230.53 K(-40.5%) |
| Dec 2014 | -$387.58 K(+4927.0%) | -$387.58 K(+40.2%) |
| Sept 2014 | - | -$276.36 K(-18.3%) |
| June 2014 | - | -$338.22 K(+198.7%) |
| Mar 2014 | - | -$113.23 K(+1368.6%) |
| Dec 2013 | -$7710.00(-110.9%) | -$7710.00(-116.0%) |
| Sept 2013 | - | $48.08 K(-67.1%) |
| June 2013 | - | $146.13 K(-38.2%) |
| Mar 2013 | - | $236.60 K(+236.0%) |
| Dec 2012 | $70.43 K(-31.6%) | $70.43 K(-72.2%) |
| Sept 2012 | - | $253.19 K(+218.1%) |
| June 2012 | - | $79.59 K(+25.0%) |
| Mar 2012 | - | $63.66 K(-38.2%) |
| Dec 2011 | $103.00 K(-47.5%) | $103.00 K(-53.1%) |
| Sept 2011 | - | $219.67 K(+54.1%) |
| June 2011 | - | $142.51 K(-10.4%) |
| Mar 2011 | - | $159.00 K(-19.0%) |
| Dec 2010 | $196.22 K(+100.6%) | $196.22 K(+132.6%) |
| Sept 2010 | - | $84.37 K(<-9900.0%) |
| June 2010 | - | -$407.00(-103.1%) |
| Mar 2010 | - | $13.15 K(-92.7%) |
| Dec 2009 | $97.80 K(-652.2%) | - |
| Oct 2009 | - | $179.84 K(-520.9%) |
| July 2009 | - | -$42.73 K(+25.8%) |
| Apr 2009 | - | -$33.96 K(+20.9%) |
| Jan 2009 | - | -$28.08 K(+15.6%) |
| Oct 2008 | - | -$24.29 K(+37.1%) |
| July 2008 | -$17.71 K(-232.2%) | -$17.71 K(+46.6%) |
| Apr 2008 | - | -$12.08 K(-615.8%) |
| Jan 2008 | - | $2342.00(-49.2%) |
| Oct 2007 | - | $4607.00 |
| July 2007 | $13.39 K | - |
FAQ
- What is Sunshine Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Sunshine Biopharma?
- What is Sunshine Biopharma annual shareholders equity year-on-year change?
- What is Sunshine Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly shareholders equity year-on-year change?
What is Sunshine Biopharma annual stockholders equity?
The current annual shareholders equity of SBFMW is $21.21 M
What is the all time high annual shareholders equity for Sunshine Biopharma?
Sunshine Biopharma all-time high annual stockholders equity is $21.63 M
What is Sunshine Biopharma annual shareholders equity year-on-year change?
Over the past year, SBFMW annual stockholders equity has changed by -$420.21 K (-1.94%)
What is Sunshine Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of SBFMW is $25.04 M
What is the all time high quarterly shareholders equity for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly stockholders equity is $41.89 M
What is Sunshine Biopharma quarterly shareholders equity year-on-year change?
Over the past year, SBFMW quarterly stockholders equity has changed by +$3.08 M (+14.00%)